Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance

(2019) Yu Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

(2019) Weimin Wang et al.   NATURE

Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma

(2019) J. Milburn Jessup et al.   Human Vaccines & Immunotherapeutics

PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

(2018) Haidong Tang et al.   JOURNAL OF CLINICAL INVESTIGATION

Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation

(2018) Wanjing Shang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epigenetic anticancer agents cause HMGB1 release in vivo

(2018) Peng Liu et al.   OncoImmunology

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

(2017) Daniela Sia et al.   GASTROENTEROLOGY

Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells

(2017) Yulia Malinovskaya et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy

(2017) Yuchen Fan et al.   NANO LETTERS

Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth

(2017) Hao Yang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability

(2017) Zhengjun Gao et al.   Nature Communications

Comparison of Three Isolation Techniques for Human Peripheral Blood Mononuclear Cells: Cell Recovery and Viability, Population Composition, and Cell Functionality

(2016) Hendrika W. Grievink et al.   BIOPRESERVATION AND BIOBANKING

Heterogeneity of liver cancer and personalized therapy

(2016) Liang Li et al.   CANCER LETTERS

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

(2016) Margaretha G.M. Roemer et al.   JOURNAL OF CLINICAL ONCOLOGY

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

(2016) Marilena Hadjidemetriou et al.   Nanoscale

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

Dendritic Cells and Cancer Immunity

(2016) Alycia Gardner et al.   TRENDS IN IMMUNOLOGY

Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma

(2016) MASANORI KAWANO et al.   Oncology Letters

Comparison of Three Isolation Techniques for Human Peripheral Blood Mononuclear Cells: Cell Recovery and Viability, Population Composition, and Cell Functionality

(2016) Hendrika W. Grievink et al.   Biopreservation and Biobanking

Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

(2015) Daniel Yuan Qiang Wong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

(2015) Ashay Jain et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Immunogenic cell death

(2015) Abhishek D. Garg et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells

(2015) Rong Sun et al.   JOURNAL OF CONTROLLED RELEASE

Liver cancer: Approaching a personalized care

(2015) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

(2015) Sylvain Ladoire et al.   OncoImmunology